Nirav Patel
Catalent, Strides Pharma Inc, Ganpat University Shree SK Patel College of Pharmaceutical Education and Research, Sardar Patel University, Taro Pharmaceuticals (Canada)
About
Dr. Nirav Patel is a distinguished expert in pharmaceutical formulation, renowned for his exceptional prowess in developing solid oral and novel dosage forms. As a dedicated pharmaceutical researcher, Dr. Patel aims to address unmet medical needs through innovative pharmaceutical advancements. He possesses extensive research experience spanning solid, liquid, semisolid, and novel dosage form development, accumulating over 15 years of expertise in product development, scale-up, technology transfer, process optimization, and GMP manufacturing.
Dr. Patel's primary research focus encompasses the development of targeted novel dosage forms, including ocular drug delivery systems, colon-targeted delivery, and floating drug delivery. His work also involves the creation of pharmaceutical products for solid oral dosage forms, incorporating comprehensive preformulation studies and cutting-edge drug delivery systems. These include nanotechnology, advanced hydrogel formulations, in-situ ophthalmic gels, and methodologies to enhance solubility and bioavailability.
With a prolific publication record in prestigious international journals,
Employment
-
Catalent Senior Development Scientist2026 - Present
-
Strides Pharma Inc Sr. Scientist2025 - 2026
-
Taro Pharmaceuticals (Canada) Specialist2023 - 2024
-
Biolab Farmacêutica Research Scientist2022 - 2023
-
Thermo Fisher Scientific Scientist2016 - 2021
-
Saurashtra University DST INSPIRE FACULTY2013 - 2016
-
Anand Pharmacy College Research Faculty2009 - 2013
-
Zydus Research Center Formulation Scientist2006 - 2008
Education
-
Ganpat University Shree SK Patel College of Pharmaceutical Education and Research Ph.D2008 - 2011
-
Sardar Patel University M. Pharm2004 - 2006
-
Hemchandracharya North Gujarat University B.Pharm2000 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- QbD-Driven Rational Design of Vancomycin-Loaded Nanocubosome In situ Ocular Gels: Augmenting Precorneal Retention and Improving Anti-MRSA Keratitis Treatment Save
- QbD-driven Formulation Development and Evaluation of Genistein Nanoparticles for Prostate Cancer Save
- Design and Development of Self-nanoemulsifying Drug Delivery System (SNEDDS) with Morin Hydrate to Enhance Nimodipine’s oral Bioavailability and Pharmacokinetics Save
- An Eco-Friendly RP-HPLC Method Development and Validation for Quantification of Favipiravir in Bulk and Tablet Dosage Form Followed by Forced Degradation Study Save
- Green synthesis of silver nanoparticles, characterization techniques and biological activities Save
- STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS DETERMINATION OF SOFOSBUVIR AND DACLATASVIR IN TABLET DOSAGE FORM Save
- Lycopene loaded polymeric nanoparticles for prostate cancer treatment: Formulation, optimization using Box-behnken design and cytotoxicity studies Save
- NOVEL AMORPHOUS SOLID DISPERSIONS OF CANAGLIFLOZIN HEMIHYDRATE IN EUDRAGIT (R) E PO Save
- Optimization of ivabradine hydrochloride transdermal patch by D-optimal mixture design: In vitro and in vivo evaluation Save
- Beneficial effect of aspirin against interferon-α-2b—induced depressive behavior in Sprague Dawley rats Save